Show simple item record

dc.contributor.authorManita, Paula Gabriela
dc.contributor.authorGarcía Orúe, Itxaso ORCID
dc.contributor.authorSantos Vizcaíno, Edorta ORCID
dc.contributor.authorHernández Martín, Rosa María ORCID
dc.contributor.authorIgartua Olaechea, Manuela ORCID
dc.date.accessioned2021-04-28T08:45:42Z
dc.date.available2021-04-28T08:45:42Z
dc.date.issued2021-04-14
dc.identifier.citationPharmaceuticals 14(4) : (2021) // Article ID 362es_ES
dc.identifier.issn1424-8247
dc.identifier.urihttp://hdl.handle.net/10810/51219
dc.description.abstractThe aim of this review is to present 3D bioprinting of skin substitutes as an efficient approach of managing skin injuries. From a clinical point of view, classic treatments only provide physical protection from the environment, and existing engineered scaffolds, albeit acting as a physical support for cells, fail to overcome needs, such as neovascularisation. In the present work, the basic principles of bioprinting, together with the most popular approaches and choices of biomaterials for 3D-printed skin construct production, are explained, as well as the main advantages over other production methods. Moreover, the development of this technology is described in a chronological manner through examples of relevant experimental work in the last two decades: from the pioneers Lee et al. to the latest advances and different innovative strategies carried out lately to overcome the well-known challenges in tissue engineering of skin. In general, this technology has a huge potential to offer, although a multidisciplinary effort is required to optimise designs, biomaterials and production processes.es_ES
dc.description.sponsorshipThis research was funded by the Spanish Ministry of Economy and Competitiveness through the “RETOS” Program (NANOGROW project, RTC-2017-6696-1) and by the Basque Government (Grupos Consolidados, IT 907-16) and through the PhD grant conceded to Paula Gabriela Maniţă (PRE_2020_2_0261).es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.relationinfo:eu-repo/grantAgreement/MINECO/RTC-2017-6696-1es_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/
dc.subjectskin bioprintinges_ES
dc.subject3D bioprintinges_ES
dc.subjectwoundses_ES
dc.subjectbioinkses_ES
dc.subjecttissue engineeringes_ES
dc.title3D Bioprinting of Functional Skin Substitutes: From Current Achievements to Future Goalses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.date.updated2021-04-23T13:31:45Z
dc.rights.holder2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).es_ES
dc.relation.publisherversionhttps://www.mdpi.com/1424-8247/14/4/362/htmes_ES
dc.identifier.doi10.3390/ph14040362
dc.departamentoesFarmacia y ciencias de los alimentos
dc.departamentoeuFarmazia eta elikagaien zientziak


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Except where otherwise noted, this item's license is described as 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).